Biomarker for detecting non-obstructive azoospermia and application thereof

A biomarker, azoospermia technology, applied in the field of biomarkers for the detection of non-obstructive azoospermia, can solve problems such as difficulty in quantitative detection

Pending Publication Date: 2022-04-15
THE FIFTH AFFILIATED HOSPITAL SUN YAT SEN UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, hsa_circMAN1A2 can be used as a circRNA marker for the diagnosis of non-obstructive azoospermia; CN112176052A discloses a plasma exosomal tsRNA marker and its application related to the diagnosis of non-obstructive azoospermia. The marker is tRF-Gly -GCC-002, which is differentially expressed in the plasma of patients with non-obstructive azoospermia and obstructive azoospermia, can better diagnose non-obstructive azoospermia. It can be seen that a variety of diagnostic NOA indicators have been developed, but These indicators are mainly concentrated in non-coding RNA, its quantitative detection is relatively difficult, and there are still some patients who cannot use these indicators to make a correct diagnosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biomarker for detecting non-obstructive azoospermia and application thereof
  • Biomarker for detecting non-obstructive azoospermia and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] This embodiment provides a diagnostic kit for non-obstructive azoospermia, which contains an antibody to TNF-α protein (NOVUS, NB600-587), a TNF-α protein standard product (NOVUS, NBC1-18460), 96-well plate, diluent, chromogenic reagent and stop solution, wherein the diluent is PBS, chromogenic reagent (substrate chromogenic solution A: take 13.6 g of sodium acetate, 1.6 g of citric acid and 0.3 mL of 30% hydrogen peroxide, add distilled water to 500mL; Substrate Chromogenic Solution B: Take 0.2g disodium edetate, 0.95g citric acid, 50mL glycerin and 0.15g TMB (dissolved in 3mL DMSO), add distilled water to 500mL, ready to use) , the stop solution is sulfuric acid.

[0044] In addition, the 96-well plate needs to be coated. The coating method is: use phosphate buffer (pH 7.2) to dilute the TNF-α protein antibody, dilute the antibody to a concentration of 500ng / mL, and add the diluted antibody to the 96-well plate , placed overnight in a refrigerator at 4°C, sealed with...

Embodiment 2

[0046] In this example, the kit in Example 1 is used to detect the semen sample.

[0047] The semen of 10 NOA patients and the semen of 10 normal men were respectively taken, and the concentration of TNF-α protein in each semen sample was detected using the kit in Example 1, including the following steps:

[0048] (1) The 80pg / mL TNF-α protein standard was diluted by comparison to obtain 80pg / mL, 40pg / mL, 20pg / mL, 10pg / mL, 5pg / mL and 0pg / mL standard solution for making a standard curve ;

[0049] (2) The new type of semen sample obtained by masturbation of the patient was placed in a 37°C water bath for 30 minutes for liquefaction;

[0050] (3) After the semen is completely liquefied, centrifuge at 3000g / 5min, and take the supernatant seminal plasma;

[0051] (4) Take 100mL of seminal plasma and standard products of various concentrations, place them in a 96-well plate coated with antibodies, and incubate at 37°C for 30min;

[0052] (5) After incubation, wash 3 times with was...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a biomarker for detecting non-obstructive azoospermia and application of the biomarker. The biomarker comprises a TNF-alpha (tumor necrosis factor-alpha) protein. The invention finds that the concentration of the Wnt receptor inhibitory protein TNF-alpha in the semen of the NOA patient is obviously lower than that of a normal male for the first time, and proposes that the TNF-alpha protein can be used as a potential early warning molecule for evaluating the spermatogenic dysfunction of the NOA patient, is beneficial to expansion and diagnosis of NOA indexes so as to expand the diagnosis range, and has important significance in the field of NOA diagnosis.

Description

technical field [0001] The invention belongs to the technical field of reproductive medicine, and relates to a biomarker for detecting non-obstructive azoospermia and its application. Background technique [0002] The incidence of azoospermia accounts for 10%-20% of male infertility. According to the presence or absence of sperm in the testes, it can be divided into two categories: one is obstructive azoospermia (OA) with normal spermatogenesis in the testis, and the other is non-obstructive azoospermia (non-obstructive azoospermia) with impaired testicular spermatogenesis. -obstructive azoospermia, NOA). An accurate diagnosis of non-obstructive azoospermia can provide valuable guidance to clinicians. [0003] Testicular volume, serum follicle-stimulating hormone (FSH) level, etc. can assist in the diagnosis of NOA patients. It has also been reported that RNA is used as a marker of NOA. For example, CN113215246A discloses a circRNA marker for the diagnosis of non-obstructi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/68
Inventor 赵亮宇汤育新戴英波叶昆周骏王紫
Owner THE FIFTH AFFILIATED HOSPITAL SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap